Machine learning approaches improve risk stratification for secondary cardiovascular disease prevention in multiethnic patients

Código QR

Machine learning approaches improve risk stratification for secondary cardiovascular disease prevention in multiethnic patients

Guardado en:

Detalles Bibliográficos
Autores principales:	Jiang Li, Fátima Rodriguez, Andrew Ward, Ashish Sarraju, David Scheinker, Sukyung Chung
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/aa43a258da2a4b6e96f81029a475255e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Secondary Prevention of Cardiovascular Disease in Women: Closing the Gap
por: Aarti Thakkar, et al.
Publicado: (2021)

Sudden Cardiac Death Risk Stratification and Prevention in Chagas Disease: A Non-systematic Review of the Literature
por: Roberto Keegan, et al.
Publicado: (2020)

Insights for Stratification of Risk in Brugada Syndrome
por: Daniel García Iglesias, et al.
Publicado: (2019)

Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Ryan Wallace, et al.
Publicado: (2021)

Time to reconsider risk stratification in dilated cardiomyopathy
por: A. Laina, et al.
Publicado: (2021)

Brugada Syndrome: Progress in Genetics, Risk Stratification and Management
por: Jorge Romero, et al.
Publicado: (2019)

The Role of C-reactive Protein in Patient Risk Stratification and Treatment
por: Ramón Arroyo-Espliguero, et al.
Publicado: (2021)

Obstructive Sleep Apnoea Syndrome: Continuous Positive Airway Pressure Therapy for Prevention of Cardiovascular Risk
por: María Pilar Resano-Barrio, et al.
Publicado: (2020)

Hypertensive Disorders in Pregnancy and the Risk of Cardiovascular Disease: A Need for Postpartum Strategies for the Primary Prevention
por: Ajay K. Gupta
Publicado: (2018)

Utility of Blood Cellular Indices in the Risk Stratification of Patients Presenting with Acute Pulmonary Embolism
por: Brett Slajus MPH, et al.
Publicado: (2021)

Cardiovascular Imaging and Theranostics in Cardiovascular Pharmacotherapy
por: Mattia Cattaneo, et al.
Publicado: (2019)

Transcatheter Aortic Valve Implantation and Subclinical and Clinical Leaflet Thrombosis: Multimodality Imaging for Diagnosis and Risk Stratification
por: María Martín, et al.
Publicado: (2021)

Cardiovascular disease and nutrition: The use of food-based dietary guidelines for prevention in Africa
por: P.T. Pisa, et al.
Publicado: (2017)

ESTIMATED AGGREGATE TREATMENT BENEFIT WITH ADDITION OF MULTIPLE NOVEL MEDICATIONS FOR SECONDARY PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
por: Robert W. Ariss, et al.
Publicado: (2021)

Comorbidity Differentiation and Risk Stratification in the Elderly Patient with Polypharmacy: A Prospective Primary Care Registry on Oral Anticoagulation Therapy
por: S van Vugt, et al.
Publicado: (2020)

Contemporary Management of Secondary Mitral Regurgitation
por: Kashish Goel, et al.
Publicado: (2020)

Cardiovascular Pharmacotherapy Focus
por: Pablo Avanzas
Publicado: (2019)

Inflammation and Cardiovascular Disease: The Future
por: Natalie Arnold, et al.
Publicado: (2021)

The Effect of Testosterone on Cardiovascular Disease and Cardiovascular Risk Factors in Men: A Review of Clinical and Preclinical Data
por: Hargun Kaur, et al.
Publicado: (2021)

Meditation and Cardiovascular Health: What is the Link?
por: Sebastian Schnaubelt, et al.
Publicado: (2019)

COVID-19 Pandemic and Cardiovascular Disease
por: Aniket S Rali, et al.
Publicado: (2020)

Deciphering the Riddles in Nutrition and Cardiovascular Disease
por: Amelia Carro, et al.
Publicado: (2019)

The Association Between Psoriasis and Cardiovascular Diseases
por: Ahmed Zwain, et al.
Publicado: (2021)

Effects of aerospace environments on the cardiovascular system
por: Erdinç Ercan
Publicado: (2021)

Post-thrombotic Syndrome: Preventative and Risk Reduction Strategies Following Deep Vein Thrombosis
por: Adam M Gwozdz, et al.
Publicado: (2020)

Novel Cardiovascular Biomarkers Associated with Increased Cardiovascular Risk in Women With Prior Preeclampsia/HELLP Syndrome: A Narrative Review
por: Esmee ME Bovee, et al.
Publicado: (2021)

Assessment of awareness of risk factors and heart healthy lifestyle as a part of routine cardiovascular evaluation in secondary prevention
por: Meral Kayıkçıoğlu
Publicado: (2021)

New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
por: Alberto J Lorenzatti, et al.
Publicado: (2020)

Viscoelastic Haemostatic Assays in Cardiovascular Critical Care
por: Aniket S Rali, et al.
Publicado: (2021)

Applications of Machine Learning in Cardiac Electrophysiology
por: Rahul G Muthalaly, et al.
Publicado: (2020)

Electronic Cigarettes and Cardiovascular Risk: Caution Waiting for Evidence
por: Domenico D’Amario, et al.
Publicado: (2019)

Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes
por: Chris Wai Hang Lo, et al.
Publicado: (2021)

Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases
por: Maki Komiyama, et al.
Publicado: (2021)

The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease
por: Pensée Wu, et al.
Publicado: (2021)

New opportunities for reducing cardiovascular risk in the Russian Federation
por: O. D. Ostroumova, et al.
Publicado: (2020)

Biomarker profile and risk stratification in cardiovascular disease during pregnancy: Action to move forward
por: Hasan Ali Farhan, et al.
Publicado: (2021)

Obesity and Cardiovascular Risk After Quitting Smoking: The Latest Evidence
por: Koji Hasegawa, et al.
Publicado: (2019)

Electronic Cigarettes and Cardiovascular Risk: Science, Policy and the Cost of Certainty
por: Olusola A Orimoloye, et al.
Publicado: (2019)

Non-invasive Low-level Tragus Stimulation in Cardiovascular Diseases
por: Yunqiu Jiang, et al.
Publicado: (2020)

Anti-inflammatory Treatment and Cardiovascular Outcomes: Results of Clinical Trials
por: Alberto J Lorenzatti
Publicado: (2021)